Stem cell research and specialized treatments.

BioStem Life Sciences

Active Pharmaceutical Ingredient repackaging and sales

Qualified Pharma Ingredients

Pharmaceutical reformulation, development and sales

Nesvik Pharmaceuticals

Recent News

BioStem Technologies Releases Third Quarter 2018 Shareholder Update

December 10, 2018

BioStem Technologies Selects PCG Advisory Group for Investor Relations and Strategic Communications

October 17, 2018

BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic...

October 1, 2018

BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex...

September 19, 2018

Please reload